SC Filed 2020-02-04 Event — SEC 0001068238-20-000035 →

Bayer Global Investments B.V. → CRISPR Therapeutics AG CRSP

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

61 transactions

13 buys · 26 sales · 22 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 11.56

19,808,194 shares short · -2.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $2.69M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-03-23	Prasad Raju	officer	Sale	3,708	$46.78	$173K
2026-03-23	Kulkarni Samarth	director, officer	Sale	10,020	$46.78	$469K
2026-03-23	KASINGER JAMES R.	officer	Sale	3,182	$46.78	$149K
2026-03-20	KASINGER JAMES R.	officer	Option exercise	6,250	—	—
2026-03-20	Kulkarni Samarth	director, officer	Option exercise	19,687	—	—
2026-03-20	Prasad Raju	officer	Option exercise	6,250	—	—
2026-03-20	Patel Naimish	officer	Award	38,499	$46.24	$1.78M
2026-03-20	Patel Naimish	officer	Award	30,000	—	—
2026-03-20	Prasad Raju	officer	Award	38,499	$46.24	$1.78M
2026-03-20	Prasad Raju	officer	Award	27,500	—	—
2026-03-20	Kulkarni Samarth	director, officer	Award	114,249	$46.24	$5.28M
2026-03-20	Kulkarni Samarth	director, officer	Award	81,875	—	—
2026-03-20	KASINGER JAMES R.	officer	Award	38,499	$46.24	$1.78M
2026-03-20	KASINGER JAMES R.	officer	Award	25,000	—	—
2026-03-16	Kulkarni Samarth	director, officer	Sale	10,349	$48.26	$499K
2026-03-16	KASINGER JAMES R.	officer	Sale	3,450	$48.26	$166K
2026-03-16	Prasad Raju	officer	Sale	5,848	$48.26	$282K
2026-03-16	Prasad Raju	officer	Sale	4,021	$48.26	$194K
2026-03-16	Prasad Raju	officer	Gift	750	—	—
2026-03-16	Patel Naimish	officer	Sale	3,150	$48.26	$152K
2026-03-14	Patel Naimish	officer	Option exercise	8,125	—	—
2026-03-14	Prasad Raju	officer	Option exercise	10,000	—	—
2026-03-14	KASINGER JAMES R.	officer	Option exercise	6,875	—	—
2026-03-14	Kulkarni Samarth	director, officer	Option exercise	20,625	—	—
2026-03-14	Prasad Raju	officer	Option exercise	6,875	—	—

Showing 25 of 61

Other 13D/G Filings on CRISPR Therapeutics AG

Filed	Form	Filer	Stake	Shares
2021-02-16	SC	Versant Ventures IV, LLC	—	—	view →
2020-01-24	SC	Bayer Global Investments B.V.	—	—	view →
2019-06-07	SC	VERTEX PHARMACEUTICALS INC / MA	—	—	view →
2018-02-13	SC	GLAXOSMITHKLINE PLC	—	—	view →
2018-02-08	SC	CELGENE CORP /DE/	—	—	view →
2018-01-16	SC	Abingworth LLP	—	—	view →

Other Filings by Bayer Global Investments B.V.

Filed	Form	Issuer	Stake	Shares
2020-01-24	SC	CRISPR Therapeutics AG CRSP	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →